Literature DB >> 28185990

A structure-activity relationship study of ABCC2 inhibitors.

Gloria Wissel1, Feng Deng1, Pavel Kudryavtsev1, Leo Ghemtio1, Peter Wipf2, Henri Xhaard3, Heidi Kidron4.   

Abstract

Multidrug resistance associated protein 2 (MRP2/ABCC2) is a membrane transport protein that can potentially affect the disposition of many substrate drugs and their metabolites. Recently, we studied the interaction of a library of 432 compounds with ABCC2, and the structure-activity relationship (SAR) of a subset of 64 compounds divided into four scaffolds (Wissel, G. et al., 2015. Bioorg Med Chem., 23(13), pp.3513-25). We have now expanded this test set by investigating 114 new compounds, of which 71 are representative of the previous four scaffolds and 43 compounds belong to a new scaffold. Interaction with ABCC2 was assessed by measuring the compounds effect on 5(6)-carboxy-2',7'-dichlorofluorescein transport in the vesicular transport assay. In line with our previous study, we observed that anionic charge is not essential for inhibition of ABCC2 transport, even though it often increases the inhibitory activity within the analogue series. Additionally, we found that halogen substitutions often increase the inhibitory activity. The results confirm the importance of structural features such as aromaticity and lipophilicity for ABCC2 inhibitory activity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MRP2; Modulator; Pharmacophore; Transporter; Vesicle assay

Mesh:

Substances:

Year:  2017        PMID: 28185990      PMCID: PMC5429213          DOI: 10.1016/j.ejps.2017.02.005

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  24 in total

1.  Quantitative structure-activity relationships of methotrexate and methotrexate analogues transported by the rat multispecific resistance-associated protein 2 (rMrp2).

Authors:  Chee Ng; Yun-De Xiao; Bert L Lum; Yong-Hae Han
Journal:  Eur J Pharm Sci       Date:  2005-09-08       Impact factor: 4.384

2.  An Aggregation Advisor for Ligand Discovery.

Authors:  John J Irwin; Da Duan; Hayarpi Torosyan; Allison K Doak; Kristin T Ziebart; Teague Sterling; Gurgen Tumanian; Brian K Shoichet
Journal:  J Med Chem       Date:  2015-08-28       Impact factor: 7.446

Review 3.  Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.

Authors:  J König; A T Nies; Y Cui; I Leier; D Keppler
Journal:  Biochim Biophys Acta       Date:  1999-12-06

4.  Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2.

Authors:  T Kamisako; I Leier; Y Cui; J König; U Buchholz; J Hummel-Eisenbeiss; D Keppler
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

5.  The canalicular multidrug resistance protein, cMRP/MRP2, a novel conjugate export pump expressed in the apical membrane of hepatocytes.

Authors:  D Keppler; J König; M Büchler
Journal:  Adv Enzyme Regul       Date:  1997

Review 6.  Emerging transporters of clinical importance: an update from the International Transporter Consortium.

Authors:  K M Hillgren; D Keppler; A A Zur; K M Giacomini; B Stieger; C E Cass; L Zhang
Journal:  Clin Pharmacol Ther       Date:  2013-04-08       Impact factor: 6.875

Review 7.  Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.

Authors:  Li Xing; Yiding Hu; Yurong Lai
Journal:  AAPS J       Date:  2009-06-03       Impact factor: 4.009

8.  Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.

Authors:  Pär Matsson; Jenny M Pedersen; Ulf Norinder; Christel A S Bergström; Per Artursson
Journal:  Pharm Res       Date:  2009-05-07       Impact factor: 4.200

9.  Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors.

Authors:  Hui Zhang; Ming-Li Xiang; Ying-Lan Zhao; Yu-Quan Wei; Sheng-Yong Yang
Journal:  Eur J Pharm Sci       Date:  2008-12-11       Impact factor: 4.384

10.  An In Silico Classification Model for Putative ABCC2 Substrates.

Authors:  Marta Pinto; Michael Trauner; Gerhard F Ecker
Journal:  Mol Inform       Date:  2012-08-09       Impact factor: 3.353

View more
  2 in total

1.  Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.

Authors:  Feng Deng; Leo Ghemtio; Evgeni Grazhdankin; Peter Wipf; Henri Xhaard; Heidi Kidron
Journal:  Mol Pharm       Date:  2020-06-18       Impact factor: 4.939

Review 2.  Models for Understanding Resistance to Chemotherapy in Liver Cancer.

Authors:  Jose J G Marin; Elisa Herraez; Elisa Lozano; Rocio I R Macias; Oscar Briz
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.